A part of Watch Media

MedWatchSaturday4 February 2023

  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Search
  • Log in
  • Latest
  • Search
  • Log in
  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
13/01/2023at 11:57

Novo Nordisk and Lundbeck prepare to help laid-off Leo employees

Christophe Bourdon, CEO of Leo Pharma, has contacted both pharmaceutical companies to find new jobs for the 300 people he fired on Thursday. Novo and Lundbeck confirm such efforts are being taken.
Around 300 people at Leo Pharma lost their jobs on Thursday | Photo: Leo Pharma/pr
by ulrich quistgaard, translated by daniel pedersen

Every cloud has a silver lining – and although 300 of Leo Pharma’s employees were let go on Thursday, they likely won’t remain unemployed for long.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters

Get full access for you and your coworkers

Start a free company trial today

Related articles:

  • Christophe Bourdon, CEO of Leo Pharma | Photo: Leo Pharma / Pr

    Leo Pharma to source new drug candidates externally following layoffs

    For subscribers

  • Photo: Magnus Møller

    Extensive layoffs at Leo Pharma – 300 jobs lost

    For subscribers

  • RICC researchers are facing a choice: to secure employment and follow Roche all the way to Switzerland; to seek out Novo Nordisk in the hopes to land a local position; or find employment elsewhere entirely | Photo: Martin Lehmann

    Roche opens Novo Nordisk career path for laid-off employees

    For subscribers

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Nu mangler kun en endelig vedtagelse i EU-Parlamentet, før lovforslag om at udskyde deadlines for nye krav til medicinsk udstyr. er en realitet. | Foto: Thomas Borberg/Ritzau Scanpix
Medtech

Another hurdle overcome in delaying MDR deadline

EU member countries have voted unanimously to adopt an EU Commission proposal to stagger the implementation of the new Medical Device Regulation. Now, only the EU Parliament’s vote remains. 
  • Asensus Surgical wins CE Mark for intelligent surgical unit under MDR rules
  • EU Commission to give more time for MDR transition

For subscribers

Foto: Stine Tidsvilde
Pharma & biotech

Novo Nordisk hopes to retain employees with share gift

For subscribers

Foto: MedWatch
Other

Top news from MedWatch this week

Luja can potentially solve a long-lived UTI problem for people who need help with bladder control issues by using new micro-hole technology
Medtech

Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps

For subscribers

Foto: Coloplast/pr
Medtech

Coloplast launches male catheter featuring new technology

For subscribers

Foto: Coloplast / Pr
Medtech

Coloplast's bottom line disappoints in otherwise strong report

For subscribers

Further reading

Foto: MedWatch
Other

Top news from MedWatch this week

Miss anything?
Foto: Leo Pharma / Pr
Pharma & biotech

Leo Pharma layoffs have no effect on listing plans

As Leo pivots from the preclinical discovering of candidates to betting on acquisitions, the company’s CEO, Christophe Bourdon, says plans to go public haven’t changed.

For subscribers

Foto: Leo Pharma / Pr
Pharma & biotech

Spokesperson: Laid-off Leo employees have leg-up in job hunt at Novo and Lundbeck

Dismissed Leo Pharma workers get to skip the line when looking for jobs at Novo Nordisk and Lundbeck via a new job tunnel – and Bavarian Nordic would like to snatch a few people up, too.

For subscribers

Latest news

  • Top news from MedWatch this week – 3 Feb
  • Coloplast to set new treatment standard with Luja – but keeps sales goal under wraps – 3 Feb
  • China accepts regulatory filing for ALK allergy tablet – 3 Feb
  • Another hurdle overcome in delaying MDR deadline – 3 Feb
  • Dupixent becomes ninefold blockbuster – 3 Feb
  • ALK forecasts lower growth in 2023 than strong 2022 result – 3 Feb
  • Unilabs and Siemens Healthineers enter million-euro strategic partnership – 3 Feb
  • Coloplast launches male catheter featuring new technology – 3 Feb
  • Novo Nordisk hopes to retain employees with share gift – 3 Feb
  • Coloplast's bottom line disappoints in otherwise strong report – 3 Feb
See all

Jobs

  • Regulatory Affairs Professional

  • Senior Clinical Project Manager

  • Clinical Operational Associate

  • Application Manager

  • Experienced Patent Counsel

  • Sr. Director, Drug Safety Physician

  • Medical Advisor (Metabolism)

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Commercial Director

  • Application Manager

  • Supply Chain Manager

  • Lead Data Architect

  • Senior Health Economics and Outcomes Research (HEOR) Manager

See all jobs

Jobs

  • Regulatory Affairs Professional

  • Senior Clinical Project Manager

  • Clinical Operational Associate

  • Application Manager

  • Experienced Patent Counsel

  • Sr. Director, Drug Safety Physician

  • Medical Advisor (Metabolism)

  • Specialist for the supply of pharmaceuticals to Danish hospitals

  • Commercial Director

  • Application Manager

  • Supply Chain Manager

  • Lead Data Architect

  • Senior Health Economics and Outcomes Research (HEOR) Manager

See all jobs

Colophon

MedWatch
Search

Sections

  • Pharma & biotech
  • Medtech
  • Hearing health
  • Regulation
  • Other
  • Sitemap
  • RSS feeds

Editor

Mikkel Aabenhus Hemmingsen

mah@medwatch.dk

Tel.: +45 3330 8387

Editor-in-chief

Anders Heering

Publisher

JP/Politiken Media Group Ltd

Advertising

annoncering@infowatch.dk

Tel.: +45 7077 7441

Advertising

Job Advertising

job@infowatch.dk

Tel.: +45 7077 7441

Jobs

Subscription

Try MedWatch or get an offer for a subscription meeting the exact needs of you or your company.

medwatch@infowatch.dk

Tel.: +45 7077 7441

Learn more about subscriptions here

Address

MedWatch

Rådhuspladsen 37

1785 Copenhagen K, Denmark

Tel.: +45 3330 8370

Guidelines

  • Privacy Policy

Copyright © MedWatch — All rights reserved

Microsoft is in the process of discontinuing Internet Explorer – and so are we.
For a better experience, we recommend using one of the following browsers.

Kind regards,
MedWatch

Google ChromeMozilla FirefoxMicrosoft Edge